Navigation Links
Infertile Voice Supports Stem Cell Research: RESOLVE Calls for,Patient Options in Using Frozen Embryos

New survey shows more than half of infertile couples willing to donate unused embryos for stem cell research

BETHESDA, Md., June 20, 2007 /PRNewswire/ -- RESOLVE: The National Infertility Association issued the following statement today, in anticipation of President Bush's veto of federal legislation that would loosen current limitations on stem cell research:

"President Bush is choosing to ignore the potential life-saving gift the infertility community is willing to give to support stem cell research - the gift of unused embryos to advance science and to help develop treatments for diseases such as cancer, diabetes and other debilitating illnesses," said Barbara Collura, Executive Director of RESOLVE: The National Infertility Association.

A recent survey of over two thousand infertile women and men with unused frozen embryos as a result of infertility treatment revealed that 60 percent would likely donate their unused embryos for stem cell research. According to Duke University Medical Center and Johns Hopkins University researchers who conducted the survey, these findings suggest that there may be upwards of 100,000 frozen embryos that could be made available for research.

"When faced with the highly emotional decision to either destroy unused embryos, donate them to another infertile couple or donate them to research, for the majority of infertile women and men, the option to donate their embryos to advance research and benefit society is the preferred choice," Collura added. "We applaud Duke and Johns Hopkins for bringing forth the patient voice in this debate. The message is loud and clear. Donating unused embryos for stem cell research is an option that should be given to infertile women and men."

"RESOLVE further believes that infertility patients should be free from interference in making the very personal decision about the uses of their own body tissues, including reproduct ive tissues and fertilized reproductive tissues," said Collura.

Founded in 1974, RESOLVE: The National Infertility Association, headquartered in Bethesda, MD, is the oldest and largest consumer-based, nonprofit group that provides education, advocacy and compassionate support for those struggling with infertility in the United States. Each year, RESOLVE and its nationwide network of affiliates and chapters handle more than 1.5 million contacts from people seeking information and help. For more information, visit the RESOLVE website at http://www.resolve.org.

    CONTACT:  Gina Cella

              Cella Communications

              Tel: 781-334-4692

              

ginacella@comcast.net

CONTACT: Gina Cella of Cella Communications for RESOLVE, +1-781-334-4692, ginacella@comcast.net

Web site: http://www.resolve.org//

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
2. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
3. Study Supports Cost-Effectiveness of Medtronics Spasticity Treatment for Children with Cerebral Palsy
4. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
5. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
6. Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse
7. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference
8. Data on Telavancin and Micafungin Hold Promise of New Therapeutic Options in Fight Against Serious Infectious Disease
9. Study Sheds Light on Medication Treatment Options for Bipolar Disorder
10. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
11. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Research ... "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural Health ... Structural electronics involves electronic and/or electrical ... structures, replacing dumb structures such as vehicle bodies ...
(Date:6/24/2016)... CLEMENTE, Calif. , June 24, 2016  American Respiratory Labs ... company, is now able to perform sophisticated lung assessments in patients, ... Technologies , Inc. Patients are no longer limited ... ndd,s EasyOne PRO ® , ARL patients like Jeanne R. of ... done in the comfort of her own home. ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology:
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
Breaking Medicine News(10 mins):